Predicting Cancer Spread in Nasopharyngeal Cancer Using AI
Part of Brain & nervous system, Cancer, Ear, nose & throat clinical trials.
This trial uses a deep learning computer model to look at tissue images and MRI scans to predict whether nasopharyngeal carcinoma may spread to other parts of the body. It may help doctors decide on the best treatment for people with certain stages of this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have nasopharyngeal carcinoma confirmed by a biopsy (a tissue sample).
- Your cancer must be at a certain stage (T3–4 or N2–3) meaning it has grown into nearby tissues or spread to neck lymph nodes.
- You must have had an MRI of the nasopharynx and neck, and also a PET/CT (or a combination of chest CT, abdominal scan, and a bone scan) to check for cancer spread.
- You cannot have had any other cancer in the past (like head/neck cancer, thyroid cancer, breast cancer, or esophageal cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a computer model can accurately detect if cancer has spread to lymph nodes in patients with nasopharyngeal carcinoma. It uses MRI and PET/CT scans taken before treatment to see if the AI can replace or supplement current methods.
This trial tests a new way of managing advanced nasopharyngeal cancer that has spread to the neck after radiation therapy. It uses regular imaging and exams to guide a less invasive neck surgery, aiming to remove any remaining cancer while preserving healthy tissue.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study looks at special blood markers (CTCs) to see how sensitive your cancer is to chemotherapy and to better predict how well treatment may work. If you have metastatic nasopharyngeal cancer and can’t have local treatment, this may help match you to more effective chemo plans.
This trial tests a new computer-based tool (deep learning) to help diagnose a condition called sbORN (suspected benign or recurrent nasopharyngeal carcinoma) after radiation therapy. It aims to see if the tool can accurately tell if a suspicious spot is a recurrence or something harmless.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
Hear when a new Nasopharyngeal Cancinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.